Regulus Therapeutics

RGLS

Market cap $565M

Delisted

RGLS was delisted on the 24th of June, 2025.

25 hedge funds and large institutions have $15M invested in Regulus Therapeutics in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 12 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New

Increased

Maintained

Reduced

Closed

1,100% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 1

120% more capital invested

Capital invested by funds: $6.8M → $15M (+$8.15M)

4.46% more ownership

Funds ownership: 47.77% → 52.23% (+4.5%)

4% less funds holding

Funds holding: 26 → 25 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders

Holders Change

-1

Holders Change %

-3.85%

% of All Funds

0.39%

Holding in Top 10

–

Holding in Top 10 Change

-1

Holding in Top 10 Change %

-100%

% of All Funds

–

New

Increased

Reduced

Closed

Calls

$580K

Puts

–

Net Calls

+$580K

Net Calls Change

+$251K

Top Buyers

1	Federated Hermes Pittsburgh, Pennsylvania	+$1.29M
2	DCM DAFNA Capital Management Los Angeles, California	+$740K
3	NMC NEA Management Company Timonium, Maryland	+$667K
4	PCM Prelude Capital Management New York	+$54.2K
5	Geode Capital Management Boston, Massachusetts	+$50.7K